GrayMatters Health

GrayMatters Health (GMH) is a health technology company developing and marketing an interventional psychiatry suite powered by digital fMRI-Informed biomarkers. Prism self-neuromodulation puts patients in the driver's seat. learning to regulate brain activity associated with their mental health condition. A growing community of psychiatry clinics across the USA is building Prism programs for personalized Depression and PTSD patient care.[1][2]

Visit website Suggest an update

2018 Founded

Overview

GrayMatters Health (GMH) is a health technology company [1][2] developing and marketing an interventional psychiatry suite powered by digital fMRI-informed biomarkers [2]. The company's product, Prism, is a self-neuromodulation platform that enables patients to learn to regulate brain activity associated with their mental health condition [2]. A growing community of psychiatry clinics across the United States has built Prism programs for personalized Depression and PTSD patient care [2]. According to LinkedIn, the company employs 32 people and operates in the mental health care industry [3].

Business address: 234 5th Avenue, New York, New York, 10001. [6]

Growth & traction

LinkedIn lists 32 people working at GrayMatters Health. [4]

Something wrong or missing? Send an update. Fixed within 24 hours.